FDA — authorised 22 December 2008
- Marketing authorisation holder: LANTHEUS MEDCL
- Status: approved
🇺🇸 GADOFOSVESET in United States
FDA authorised GADOFOSVESET on 22 December 2008
Marketing authorisation
GADOFOSVESET in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is GADOFOSVESET approved in United States?
Yes. FDA authorised it on 22 December 2008.
Who is the marketing authorisation holder for GADOFOSVESET in United States?
LANTHEUS MEDCL holds the US marketing authorisation.